RxDoctor Payments DataLook up a doctor →

Jeffrey Unger, MD

Family Medicine · Chino, CANPI 1003856188

Payments from drug & device makers

$1,715,395in general payments, 2019–2025

Across 1,358 payments — averaging $1263.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$752K
  • Abbott$323K
  • Novo Nordisk$308K
  • Corcept Therapeutics$130K
  • Novo Nordisk AS$49K
  • Bayer$28K
  • plus $126K from 33 others
$900in research payments, 2019–2025

Across 3 payments — averaging $300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi-aventis U.S. LLC$750
  • Indivior Inc.$150

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,715,395 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$70,079
Medicare patients
69
Services billed
1,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Chino

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →